BASF and Bota Biosciences jointly launched SkinNexus™ Collag3n, a 100% human-identical recombinant Collagen III

“SkinNexus™ Collag3n” merges Bota’s Physical AI-driven biofoundry capabilities with BASF’s technology for cosmetic actives. Drawing on their combined expertise in AI, synthetic biology, skin science, and biomanufacturing, Bota and BASF screened over 2,000 collagen fragments. Candidate evaluation ran in parallel with industrial feasibility validation and finally commercialized by BASF.

SkinNexus™ Collag3n is a recombinant, vegan Collagen III fragment produced by yeast fermentation with a 100% human-identical sequence. According to the supplier, in 3D dermis models the ingredient was shown to support a healthy environment for full-spectrum collagen homeostasis (+48% Collagen I, +82% Collagen III, +71% Collagen V). The supplier reports that clinical trials on women aged 53–70 showed improvements in sagging and wrinkle appearance after four weeks, outperforming a collagen benchmark used at ten times the concentration.

This collaboration is proof that Physical AI for Biomanufacturing can turn cutting-edge science into commercial, sustainable, high-performance ingredients with new standards for bio-identical actives in personal care.

3
Show Comments (0) Hide Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x